Filter posts

BIO Is Almost Here – What To Consider Before Entering New Therapeutic Areas

Over the past decade, the biopharmaceutical industry has witnessed a shift towards specialty care. From …

The International Space Station Brings Big Buzz and Big Science to BIO 2015

This year, the BIO International Convention will raise the bar, yet again, through a collaborative …

BIO Deputy General Counsel Testifies on Patent Reform

On Wednesday, March 18, BIO’s Deputy Counsel for Intellectual Property, Hans Sauer, testified in front …

Upcoming Panel will Highlight The Successes of The NCATS Tech Transfer Model

On October 29, 2014 the Center for Clean Energy Innovation and the House Technology Transfer …

Synthetic Biology: The Sword in the Stone to Defeat Devastating Diseases

On July 17th, 2014 the House held a hearing titled: Subcommittee on Research and Technology …

Wanted: Tax Policies to Support Innovation

Innovative small businesses work to advance research, development, and manufacturing of technologies to help solve …

Patents Improve Public Health: Progressive Economy Reviews TRIPS at 20 Years

Progressive Economy released a research paper examining the effect of TRIPS (Trade-Related Aspects of Intellectual …

The Pivotal Role the Public Market Plays in Financing R&D

Growing innovators are the heart of our industry. Biotech small businesses face a dual struggle …

How to Survive the Patent Cliff: Eli Lilly’s CEO at the BIO CEO & Investor Conference

Like a number of companies, Eli Lilly is confronting a wave of patent expirations called …

Data Exclusivity Protects Innovators and Assures Investors

Biotechnology companies must have some certainty that they can protect their investment in the development …